Brice Ozenne

4.0k total citations · 1 hit paper
105 papers, 2.5k citations indexed

About

Brice Ozenne is a scholar working on Cognitive Neuroscience, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Brice Ozenne has authored 105 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cognitive Neuroscience, 27 papers in Cellular and Molecular Neuroscience and 19 papers in Pharmacology. Recurrent topics in Brice Ozenne's work include Functional Brain Connectivity Studies (25 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Treatment of Major Depression (19 papers). Brice Ozenne is often cited by papers focused on Functional Brain Connectivity Studies (25 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Treatment of Major Depression (19 papers). Brice Ozenne collaborates with scholars based in Denmark, France and United Kingdom. Brice Ozenne's co-authors include Gitte M. Knudsen, Patrick M. Fisher, Dea Siggaard Stenbæk, Delphine Maucort‐Boulch, Fabien Subtil, Claus Svarer, M. Madsen, Melanie Ganz, Daniel Burmester and Kristían Línnet and has published in prestigious journals such as Journal of Neuroscience, Journal of the American Statistical Association and PLoS ONE.

In The Last Decade

Brice Ozenne

97 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

2019 338 citations M. Madsen, Patrick M. Fisher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brice Ozenne Denmark	22	1.0k	783	606	351	258	105	2.5k
Nicolás Crossley United Kingdom	26	437 0.4×	364 0.5×	117 0.2×	2.0k 5.8×	92 0.4×	78	3.4k
Christina N. Lessov‐Schlaggar United States	26	297 0.3×	362 0.5×	81 0.1×	2.3k 6.4×	149 0.6×	61	4.6k
Kaifeng Lu United States	29	268 0.3×	344 0.4×	56 0.1×	117 0.3×	95 0.4×	87	3.3k
Pilar Lim United States	31	583 0.6×	991 1.3×	90 0.1×	442 1.3×	119 0.5×	76	5.9k
Peter Bentham United Kingdom	28	275 0.3×	283 0.4×	33 0.1×	241 0.7×	101 0.4×	63	3.2k
Michelle Gee United Kingdom	17	220 0.2×	525 0.7×	40 0.1×	268 0.8×	52 0.2×	26	3.8k
J. Wesson Ashford United States	39	156 0.2×	566 0.7×	36 0.1×	868 2.5×	147 0.6×	147	5.2k
Shelia Jin United States	16	99 0.1×	207 0.3×	71 0.1×	270 0.8×	115 0.4×	28	3.9k
Alireza Atri United States	35	137 0.1×	475 0.6×	49 0.1×	1.2k 3.5×	110 0.4×	119	5.0k
Michael S. Rafii United States	33	104 0.1×	410 0.5×	49 0.1×	502 1.4×	121 0.5×	112	4.8k

Countries citing papers authored by Brice Ozenne

Since Specialization

Citations

This map shows the geographic impact of Brice Ozenne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brice Ozenne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brice Ozenne more than expected).

Fields of papers citing papers by Brice Ozenne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brice Ozenne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brice Ozenne. The network helps show where Brice Ozenne may publish in the future.

Co-authorship network of co-authors of Brice Ozenne

This figure shows the co-authorship network connecting the top 25 collaborators of Brice Ozenne. A scholar is included among the top collaborators of Brice Ozenne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brice Ozenne. Brice Ozenne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Larsen, Søren Vinther, Brice Ozenne, Anders Pretzmann Mikkelsen, et al.. (2025). Postpartum Hormonal Contraceptive Use and Risk of Depression. JAMA Network Open. 8(3). e252474–e252474.

Miskowiak, Kamilla Woznica, Julian Macoveanu, Brice Ozenne, et al.. (2025). Relation Between Brain Morphological Features and Psychiatric Hospitalization Risk in Major Depressive and Bipolar Disorders. Acta Psychiatrica Scandinavica. 151(6). 689–697. 1 indexed citations

Ozenne, Brice, et al.. (2025). Whole blood BDNF is lower in patients with depression and unchanged by escitalopram in patients and healthy controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 141. 111470–111470. 1 indexed citations

Jensen, Per, Brice Ozenne, Per Meden, et al.. (2025). Poststroke Translocator Protein Expression Dynamics and Correlations to Chronic Infarction: A ^[123I] ‐CLINDE‐SPECT Study. Journal of Neuroimaging. 35(1). e70002–e70002. 1 indexed citations

Jensen, Kristian H. R., Vibeke H. Dam, Brice Ozenne, et al.. (2024). Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder. Journal of Psychiatric Research. 181. 197–205.

Ozenne, Brice, Vibeke H. Dam, Martin Balslev Jørgensen, et al.. (2024). Rumination in patients with major depressive disorder before and after antidepressant treatment. Journal of Affective Disorders. 360. 322–325. 2 indexed citations

Piffoux, Max, et al.. (2024). Restricted Net Treatment Benefit in oncology. Journal of Clinical Epidemiology. 170. 111340–111340.

Beliveau, Vincent, Brice Ozenne, M. Madsen, et al.. (2024). Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression. The British Journal of Psychiatry. 226(3). 137–143. 2 indexed citations

Larsen, Søren Vinther, Anders Pretzmann Mikkelsen, Brice Ozenne, et al.. (2024). Association Between Intrauterine System Hormone Dosage and Depression Risk. American Journal of Psychiatry. 181(9). 834–841. 7 indexed citations

10.

Sankar, Anjali, Brice Ozenne, Vibeke H. Dam, et al.. (2024). Neocortical serotonin 2A receptor binding, neuroticism and risk of developing depression in healthy individuals. Nature Mental Health. 2(10). 1231–1238. 2 indexed citations

11.

Ozenne, Brice, Søren Vinther Larsen, Claus Svarer, et al.. (2023). Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study. The International Journal of Neuropsychopharmacology. 26(9). 639–648. 1 indexed citations

12.

Larsen, Søren Vinther, Brice Ozenne, Dea Siggaard Stenbæk, et al.. (2023). Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression—a NeuroPharm study. Translational Psychiatry. 13(1). 247–247. 3 indexed citations

13.

Jensen, Kristian H. R., Vibeke H. Dam, Melanie Ganz, et al.. (2023). Deep phenotyping towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort. BMC Psychiatry. 23(1). 151–151. 5 indexed citations

14.

Ozenne, Brice, Søren Vinther Larsen, Vibeke H. Dam, et al.. (2022). Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study. Translational Psychiatry. 12(1). 273–273. 13 indexed citations

15.

Fisher, Patrick M., Brice Ozenne, Melanie Ganz, et al.. (2022). Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: A NeuroPharm study. Journal of Psychopharmacology. 36(5). 626–636. 15 indexed citations

16.

Madsen, M., Dea Siggaard Stenbæk, Sophia Armand, et al.. (2021). Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience. European Neuropsychopharmacology. 50. 121–132. 83 indexed citations

17.

Dam, Vibeke H., Dea Siggaard Stenbæk, Cheng-Teng Ip, et al.. (2020). Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study. Psychological Medicine. 51(14). 2347–2356. 18 indexed citations

18.

Péron, Julien, Pascal Roy, Thierry Conroy, et al.. (2016). An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma. Oncotarget. 7(50). 82953–82960. 21 indexed citations

19.

Péron, Julien, Pascal Roy, Brice Ozenne, Laurent Roche, & Marc Buyse. (2016). The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials. JAMA Oncology. 2(7). 901–901. 41 indexed citations

20.

Ozenne, Brice, Fabien Subtil, & Delphine Maucort‐Boulch. (2015). The precision–recall curve overcame the optimism of the receiver operating characteristic curve in rare diseases. Journal of Clinical Epidemiology. 68(8). 855–859. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact